Objectives: To test the usefulness of procalcitonin serum level for the reduction of antibiotic consumption in intensive care unit patients.
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For information regarding this article, E-mail: pdamas@chu.ulg.ac.be A ntibiotics are known to carry a high burden in the intensive care unit (ICU) setting, leading to an increased risk of bacterial resistance and higher treatment-related costs (1) . ICU caregivers are daily challenged by the necessity of a prompt initiation of antibiotics in the setting of sepsis (2, 3) while avoiding misuse in the absence of infection (4, 5) . A potentially discriminant biomarker could therefore prove to be helpful (6) . Recently, it was shown that procalcitonin (PCT) guidance of antibiotic therapy reduced antibiotic consumption by almost 50% in patients suspected of having either a community-acquired pneumonia or an exacerbation of chronic obstructive pulmonary disease (7) (8) (9) . The same strategy was recommended for ICU patients suspected of developing an infectious process (10) .
In this context, the present study was designed to test the hypothesis that antibiotic consumption differs between patients with PCT guidance and those without PCT guidance for the decision to treat. Secondary objectives included the assessment of the quality of infectious-disease (ID) diagnosis by the ICU physician and determination of its concordance with the ID specialist's diagnosis. The latter was blinded to PCT results.
MATERIALS AND METHODS
From April 2008 to December 2008, patients older than 18 yrs of age and hospitalized for >2 days in one of the five ICUs of the University Hospital of Liege (Liège, Belgium) were prospectively randomized to either a PCTguided approach to antibiotic therapy (PCT group) or to a standard approach (Control group) in which the physician was blinded to PCT result, PCT levels being obtained in all suspected episodes of infection. The study was approved by the institutional ethics comity, and written or oral consent was obtained from all patients or their next of kin.
Age, sex, Simplified Acute Physiology Score II calculated during the first 24 hrs after admission to the ICU, as well as underlying diseases according to the McCabe classification were recorded. Admissions were classified into trauma, unscheduled surgery, scheduled surgery, or medical. Patients readmitted to the ICU during the study period remained in the same group (PCT or Control). For each patient, the total ICU stay was calculated, and all infectious episodes were recorded to account for the total antibiotic consumption throughout the study period. The patient's course of illness was characterized by the Sequential Organ Failure Assessment score measured daily and the Sequential Organ Failure Assessmentmax calculated for the first ICU stay as proposed by Moreno et al (11) .
As soon as patients were suspected of developing an infection, a serum PCT was ordered and its level was revealed to physicians of the PCT group, while it was blinded to those of the Control group. According to the proposal by Müller et al, for patients in the PCT group, the use of antibiotics was more or less strongly discouraged if PCT level was <0.25 µg/L or 0.50 µg/L, respectively, and more or less recommended if PCT level was above 1 µg/L or 0.50 µg/L, respectively (10) . This strategy was applied to all infectious episodes encountered during their ICU stay. Infections were defined on the basis of clinical history, symptoms, physical examination, and laboratory findings. They were also characterized according to mode of acquisition (community, hospital, or ICU-acquired), source, and microbiological documentation. The severity of infection was assessed according to the American College of Chest Physicians/Society of Critical Care Medicine Conference Guidelines on the grade of sepsis (12) . Clinicians involved in the decision to treat were also asked to rate their diagnosis as certain, probable, possible, or unlikely. At the end of ICU stay, patients' charts were reviewed by ID specialists blinded to PCT results, who classified them as confirmed, probable, possible, or no infection using all the clinical data and biological results including microbiological cultures and results from investigational procedures.
PCT results in the control group were eventually unblinded for the statistical analysis.
PCT serum level was measured using a timeresolved amplified cryptate emission technology assay (Kryptor PCT; Pasteur Mérieux, Paris, France) with a functional assay sensitivity of 0.06 µg/L. Antibiotic consumption was evaluated by counting the days of therapy expressed as treatment days and by the amounts of antibiotics expressed as daily defined dose (DDD) (13) .
The primary end point was the difference of antibiotic consumption between the PCT group and the control group. Secondary end points included: usefulness of PCT levels in the ICU diagnostic algorithm in deciding whether to initiate antibiotics or not whenever infection was suspected, and determination of concordance of the infection's diagnostic ratings by the ICU physician and the ID specialist, bearing in mind that the latter was blinded to PCT results in all of the cases.
Statistical Analysis. Continuous variables were reported as mean ± sd for normally distributed variables or as median and interquartile range (IQR) for variables with skewed distribution. Proportions were compared by the chi-square test while mean values were compared by one-way analysis of variance of the Kruskal-Wallis test. Interobserver agreement between clinicians and ID specialists was assessed by Cohen's kappa coefficient. Assuming a mean stay of 7 days with 50% antibiotic exposure, a study sample of at least 250 patients in each group was deemed necessary to detect a 20% reduction in antibiotic consumption with 95% power at the 5% significance level.
RESULTS
During the study period, 1501 patients were admitted to the five ICUs (see Fig.  1 ). Among them, 854 were expected to stay for ≤48 hrs, and 138 did not give informed consent. Five hundred and nine patients were eligible for the study and randomized into the PCT group (n = 258) and the control group (n = 251). The baseline characteristics of patients at admission were comparable in both groups in terms of age, sex, type of admission, comorbidities, and Simplified Acute Physiology Score II score ( Table 1) .
The characteristics of the ICU stay are given in Table 2 : among the 509 study patients, 227 in the PCT group (88%), and 214 in the control group (85.3%) had at least one suspected episode of infection. Together, these 441 patients presented 667 episodes of suspected infections (323 on admission to ICU and 344 during ICU stay) yielding a number of infectious episodes of 1.4 ± 1.1 episodes per patient in the PCT group and 1.2 ± 1 episodes per patient in the control group (p = .15). PCT results were available for 389 (88.2%) of the 441 patients. There were more patients with PCT results in the PCT group than in the control group (81.8% vs. 70.9%, p = .005), and so was the number of PCT results per patient (1.2 ± 1.0 vs. 0.8 ± 0.8; p = .003). The length of stay, Sequential Organ Failure Assessmentmax, number of patients with renalreplacement therapy and ventilation, duration of ventilation, and ICU mortality were similar in both groups.
Antibiotic consumption did not differ between groups: the treatment days represented 62.6 ± 34.4% and 57.7 ± 34.4% of the ICU stays in the PCT and control groups, respectively (p = .11). Similarly, there was no difference in terms of DDD/100 ICU days between the two groups: a mean of 147.3 ± 206.00 DDD/100 ICU days in the PCT group vs. 141.1 ± 136.9 DDD/100 ICU days in the control group, or a median of 108.3 (IQR 47.7-200) DDD/100 ICU days in the PCT group vs. 108.7 (IQR 52.3-180.7) DDD/100 ICU days in the control group (p = .96).
The characteristics of the 667 infectious episodes observed in the two groups are displayed in Table 3 . The source of infection was predominantly respiratory (62.8%). Severe sepsis or septic shock were encountered in almost half of the infectious episodes (47.5%). Infection was bacteriologically documented in 61.5% of the cases, and ID specialists confirmed the diagnosis as certain or probable in 61.7% of the cases. No differences were noted between infectious episodes in the two groups. PCT levels were compared according to the bacteriological results of episodes considered at least as possible by ID specialists: PCT levels (median and IQR) were 1. Table 4 displays the number of withheld treatments in both groups according to the clinician's confidence; all episodes classified as certain were treated with antibiotics. For the episodes classified as possible, the proportion of withheld treatments was significantly higher in the PCT group as compared to those in the control group (50.5% vs. 34.2 %; p = .034).
When looking at the decision to treat according to PCT level in both groups, no difference between PCT and control groups could be observed (Table 5 ). PCT levels were >1 µg/L in 259 episodes (48.3% of 536 cases with PCT measurement) and <0.25 µg/L in 135 episodes (25.2%). There was a trend toward a higher proportion of withheld treatment in suspected sepsis with PCT level < 0.25 µg/L in the PCT group (37 of 80, 46%) vs. the control group (18 of 55, 32.7%, p = .15). Fortythree episodes with PCT levels <0.25 µg/L in the PCT group were nevertheless treated by antibiotics: these were lower-tract respiratory infections (n = 27), intraabdominal infections (n = 2), soft-tissue infections (n = 4), sepsis (n = 9), and cryptococcosis (n = 1). Fifteen of these episodes of infection (34.9%) presented as severe sepsis or septic shock, 10 (23%) were accompanied by bloodstream infections (three S. aureus, one coagulase negative Staphylococcus, two Streptococcus faecalis, and four Enterobacteriaceae). At the end of the ICU stay, ID specialists classified these 43 episodes as certain (n = 18, 41.8%), probable (n = 12, 27.9%), possible (n = 4, 9.3%), or absence of infection (n = 9, 20.9%). By contrast, 16 episodes in the PCT group with PCT levels >1 µg/L were not treated. ID specialist a posteriori confirmed the absence of infection in 10 of them; only one should have been treated for an empyema which was, in fact, diagnosed 1 day later. The 15 other episodes turned out to be acute pulmonary edema (n = 4), pneumothorax at day 5 after cardiac surgery (n = 1), pericardial effusion with tamponade at day 5 after cardiac surgery (n = 1), hemorrhagic shock (n = 1), subdural hematoma (n = 1), ruptured aortic abdominal aneurysm (n = 1), toxic hepatitis (n = 1), lactic acidosis with acute renal failure secondary to drug abuse (n = 1), diabetic ketoacidosis (n = 1), acute pancreatitis (n = 1), acute exacerbation of chronic obstructive pulmonary disease (n = 1), and microbiologically nonconfirmed catheterrelated infection (n = 1). Considering the 259 suspected infectious episodes with a PCT level >1 µg/L, 46 (17.8%) were not confirmed by the ID specialist. Figure 2 displays the distribution of PCT levels according to the ID specialist's diagnostic confidence upon reviewal of the charts. A statistically significant difference was found between the four PCT distributions (p < .0001) but also a large overlap between the results. In fact, 33.8% of the cases in which no infection was confirmed had a PCT value > 1 µg/L, and 14.9% with confirmed infection had PCT levels < 0.25 µg/L. The ability of PCT levels to differentiate between certain or probable infection and possible or no infection, upon initiation of antibiotic treatment, as assessed by ID specialists, was low as confirmed by ROC curve analysis (AUC = 0.69) (Fig. 3) . The observed proportion of agreement between the ICU clinician and the ID specialist was 53% for the PCT group and 49% for the control group (not significant), yielding a kappa coefficient of 0.46 in both groups.
Lastly, the ICU length of stay and mortality were the same in both groups of patients.
DISCUSSION
In this study, we failed to show a significant reduction in antibiotic consumption when considering PCT as a diagnostic tool for the initiation of antibiotics for critically ill patients in whom sepsis is suspected. Although ICU clinicians could significantly decrease the number of treatments when infection was considered as possible and when PCT was available (Table 4) , the overall consumption was the same between the two groups. A reason for this failure may be that almost half of PCT serum samples were >1 µg/L thus encouraging the antibiotic treatment. Only 25% of the samples were below the lowest cutoff. A second reason might lie in the fact that clinical skills and judgment superseded PCT results and protocol recommendations since only 46.3% of the patients with a low level of PCT were not treated. Indeed, 43 patients had signs of severe sepsis and/or comorbidities that prompted physicians to treat them. It must be emphasized that the majority of these treatments (30 of 43, 69.8%) were a posteriori confirmed as correct by the ID specialist. A third reason could be that in this study the proportion of patient-days with antibiotic treatment in the control group was already low (57%) compared to other studies (14) in which that proportion was >80%.
However, the main question raised by our study is the accuracy of PCT as a marker of infection. This is a question that has been already raised by others (15) (16) (17) . In our study, 33.8% of episodes with no confirmed infection had a PCT value >1 µg/L, potentially leading to SOFAmax, sum of all the dysfunction and failure occurring during the intensive care unit stay according to the Sequential Organ Failure Assessment score. antibiotic misuse, and 14.9% episodes with confirmed infection had PCT levels < 0.25 µg/L. Thus the area under the receiving operating curve was disappointingly 0.69, which is too low to propose PCT as a marker of infection in ICU patients, at least in the setting of deciding whether to initiate or withhold antibiotics. Our study did not confirm the positive results of two recently published studies investigating the impact of PCT levels on the reduction of antibiotic consumption in critically ill patients (14, 18) . The impact of serial PCT measurements as studied by Bouadma et al and Nobre et al ultimately determined treatment duration, which was not our primary objective (14, 18) . The present study was designed to analyze the impact of PCT in a diagnostic strategy of infection and also to verify the accuracy of PCT as a marker of infection. To the best of our knowledge, the a posteriori reviewal of the charts and confirmation or rejection of infection by a blinded to PCT ID specialist has not been described in the ICU setting yet. Rather than the potential recurrent infection or excess mortality possibly caused by an inappropriate antimicrobial treatment driven by a PCT-guided strategy, the validation of true infection by an ID specialist in possession of all the clinical and final microbiological data appears to be more appropriate in recommending a particular strategy. It has been validated in febrile patients presenting to the emergency department (19) .
The present study has weaknesses: First, its single-center design may be criticized. Second, the high number of surgery and trauma patients (40.7%) in our population could also be outlined in terms of case mix, since it is known that these conditions can induce early increase in PCT levels, causing false positives. However, infection occurring after trauma or surgery usually appears after several days, which allows PCT to come back to baseline value. Furthermore, surgical or trauma patients represent a substantial part of the critically ill patients hospitalized in the ICU. It was important to consider them in a systematical approach designed to reduce antibiotic consumption and misuse. Third, for obvious reasons, it was not possible to design a blind study in this setting. Some results of our study emphasize the bias provoked by the open design: clinicians aware of PCT availability for patients belonging to the PCT group, tended to suspect occurrence of sepsis more often in this group. The number of suspected episodes was slightly higher in PCT group (Table 2) , the least confident classes (uncertain and possible) were also a little bit higher in this group and the proportion of bacteriologically documented infection was lower in the PCT group with a trend toward significance (p = .06, Table 3 ). Nevertheless this bias per se did not modify the decision to treat algorithms which followed classical recommendations (10) . Fourth, the fact that no serial determinations of PCT throughout the antibiotic course were programmed upfront in the design of the study, for reasons of cost, is probably partly responsible for the negative finding considering reduction of antibiotic consumption, although some recent data suggest the opposite (20) .
In conclusion, considering PCT levels for initiating antibiotic treatment did not appear to be helpful in a strategy aimed at decreasing the antibiotic consumption in critically ill patients. In addition, PCT proved to be a poor marker of infection when considering the accuracy of infection diagnosis made by the ICU clinician and the a posteriori reviewal by an ID specialist blinded to PCT result. These are the reasons why we cannot, at this point, recommend a PCT-guided strategy for the initiation of antibiotics in critically ill patients.
